L Méndez1, A Bernal, P Escudero
1Servicio de Ginecología Oncológica, Hospital Luis Castelazo Ayala, México, D.F.
Pelvic exenteration for persistent or recurrent cervical cancer showed a 5.8% operative mortality. Survival significantly depended on tumor status, with recurrent tumors having better outcomes than persistent ones.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: